AI-based image analysis models can predict cancer biomarkers and patient survival more accurately than conventional methods, enhancing treatment outcomes. Caris Life Sciences' AI model analyzed over ...
n this study, 773 untreated breast cancer patients from all over China were collected and followed up for at least 5 years. We obtained clinical data from 773 cases, RNA sequencing data from 752 cases ...
Final Phase 2 Bria-IMT median overall survival (OS) is 16.6 months (with Phase 3 formulation) Positive Quality of Life (QOL) data from the ...
A ‘big’ data study links the diabetes and weight-loss drugs to better long-term survival after breast cancer. Critics are ...
UBC Okanagan researchers, working with scientists at BC Cancer–Kelowna, have developed a groundbreaking AI model that can ...
HER2-positive breast cancer accounts for about 20% of breast cancer cases and is generally associated with more aggressive ...
Using claims data instead of self-reports, a team of researchers in Germany evaluated adherence to endocrine therapy on recurrence and mortality in early breast cancer. High adherence to endocrine ...
Although the oncology community is buzzing with the potential of circulating tumor DNA (ctDNA) to revolutionize breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results